Combined administration of catalpol, puerarin, gastrodin, and borneol modulates the Tlr4/Myd88/NF-κB signaling pathway and alleviates microglia inflammation in Alzheimer’s disease. This evidence concerns the gene TLR4 and early-onset autosomal dominant Alzheimer disease.